← Open Payments lookup

ANDRAS FENYVES: Open Payments

NPI 1952467318 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$454 in 20 payments from 10 companies in 2025. Trend: 2023 $255 · 2024 $589 · 2025 $454

Food & beverage: $454
CompanyPaymentsAmount
Lilly USA, LLC3$80
ABBVIE INC.4$76
Biogen, Inc.4$67
Otsuka America Pharmaceutical, Inc.2$47
Amgen Inc.2$37
Novo Nordisk Inc1$34
Bayer Healthcare Pharmaceuticals Inc.1$34
Axsome Therapeutics, Inc.1$29
Xeris Pharmaceuticals, Inc.1$25
Dexcom, Inc.1$23

Products named: MAVYRET, SKYCLARYS, MOUNJARO, REXULTI, OTEZLA, Ozempic, Kerendia, ZEPBOUND.

Industry payments across NY — which companies pay providers there.